• Please log in or register to access this feature.

Coccidioidomycosis

Management of coccidioidomycosis in patients receiving biologic response modifiers or disease-modifying antirheumatic drugs

  1. Sara Taroumian1,*,
  2. Susan L. Knowles2,
  3. Jeffrey R. Lisse2,
  4. James Yanes2,
  5. Neil M. Ampel3,
  6. Austin Vaz4,
  7. John N. Galgiani2,
  8. Susan E. Hoover2

Article first published online: 28 NOV 2012

DOI: 10.1002/acr.21784

Issue

Arthritis Care & Research

Arthritis Care & Research

Volume 64, Issue 12, pages 1903–1909, December 2012

Additional Information

How to Cite

Taroumian, S., Knowles, S. L., Lisse, J. R., Yanes, J., Ampel, N. M., Vaz, A., Galgiani, J. N. and Hoover, S. E. (2012), Management of coccidioidomycosis in patients receiving biologic response modifiers or disease-modifying antirheumatic drugs. Arthritis Care Res, 64: 1903–1909. doi: 10.1002/acr.21784

Author Information

  1. 1

    University of Arizona, Tucson, and University of California, Los Angeles

  2. 2

    University of Arizona, Tucson

  3. 3

    Southern Arizona VA Health Care System and University of Arizona, Tucson

  4. 4

    Catalina Pointe Rheumatology, Tucson, Arizona

*200 University of California, Los Angeles Medical Plaza, Suite 365-B, Box 951685, Los Angeles, CA 90095-1685

Publication History

  1. Issue published online: 28 NOV 2012
  2. Article first published online: 28 NOV 2012
  3. Accepted manuscript online: 28 JUN 2012 09:31AM EST
  4. Manuscript Accepted: 16 JUN 2012
  5. Manuscript Received: 14 MAR 2012

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (137K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Rhina D. Castillo, Wendy Pena, Katherine A. B. Marzan, Diagnosis and Management of Infectious Complications of Childhood Rheumatic Diseases, Current Rheumatology Reports, 2013, 15, 4

    CrossRef

View Full Article (HTML) Get PDF (137K)